Cholesterol in mild cognitive impairment and Alzheimer's disease in a birth cohort over 14 years

European Archives of Psychiatry and Clinical Neuroscience

Volumn 264, Issue 6, 2014, Pages 485-492

  Toro, P ^a,b   Degen, Ch ^a   Pierer, M ^c   Gustafson, D ^d,e   Schroder J ^a   Schonknecht P ^a,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

AACD; AD; APOE; Cholesterol; ILSE; MCI

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; AGING; ALLELE; ALZHEIMER DISEASE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN DEVELOPMENT; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SMOKING; WORD LIST RECALL; ATTENTION; BLOOD; COHORT ANALYSIS; GENETICS; LEARNING; MEMORY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; SURVIVAL; THINKING; VERY ELDERLY; VISION; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; ATTENTION; CHOLESTEROL; COHORT STUDIES; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SURVIVAL ANALYSIS; THINKING; VERBAL LEARNING; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84906934444     PISSN: 09401334     EISSN: 14338491     Source Type: Journal    
DOI: 10.1007/s00406-013-0468-2     Document Type: Article

References (42)

1. Schonknecht P, Lutjohann D, Pantel J, Bardenheuer H, Hartmann T, von Bergmann K, Beyreuther K, Schroder J (2002) Cerebrospinal fluid 24S-hydroxycholesterol is increased in patients with Alzheimer's disease compared to healthy controls. Neurosci Lett 324(1):83-85 (Pubitemid 34442684)
2. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Iivonen S, Mannermaa A, Tuomilehto J, Nissinen A, Soininen H (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137(3):149-155 (Pubitemid 34827510)
3. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 64(2):277-281. doi:10.1212/01.WNL.0000149519.47454.F2
4. Solomon A, Kareholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology 68(10):751-756. doi:10.1212/01.wnl.0000256368.57375.b7 (Pubitemid 46667900)
5. Kivipelto M, Solomon A (2006) Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence. Acta Neurol Scand Suppl 185:50-57. doi:10.1111/j.1600-0404.2006.00685.x (Pubitemid 44015225)
6. Anstey KJ, Lipnicki DM, Low LF (2008) Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry 16(5):343-354. doi:10.1097/JGP. 0b013e31816b72d4
7. Wolozin B, Wang SW, Li NC, Lee A, Lee TA, Kazis LE (2007) Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med 5:20. doi:10.1186/1741-7015-5-20
8. Li G, Larson EB, Sonnen JA, Shofer JB, Petrie EC, Schantz A, Peskind ER, Raskind MA, Breitner JC, Montine TJ (2007) Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease. Neurology 69(9):878-885. doi:10.1212/01.wnl.0000277657.95487.1c (Pubitemid 47329587)
9. Mielke MM, Zandi PP, Shao H, Waern M, Ostling S, Guo X, Bjorkelund C, Lissner L, Skoog I, Gustafson DR (2010) The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology 75(21):1888-1895. doi:10.1212/WNL.0b013e3181feb2bf
10. Stewart R, White LR, Xue QL, Launer LJ (2007) Twenty-sixyear change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study. Arch Neurol 64(1):103-107. doi:10.1001/archneur.64.1.103 (Pubitemid 46072431)
11. Tokuda T, Calero M, Matsubara E, Vidal R, Kumar A, Permanne B, Zlokovic B, Smith JD, Ladu MJ, Rostagno A, Frangione B, Ghiso J (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J 348(Pt 2):359-365 (Pubitemid 30345209)
12. Howland DS, Trusko SP, Savage MJ, Reaume AG, Lang DM, Hirsch JD, Maeda N, Siman R, Greenberg BD, Scott RW, Flood DG (1998) Modulation of secreted beta-amyloid precursor protein and amyloid beta-peptide in brain by cholesterol. J Biol Chem 273(26):16576-16582 (Pubitemid 28311445)
13. Schroder J, Kratz B, Pantel J, Minnemann E, Lehr U, Sauer H (1998) Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm Suppl 54:51-59 (Pubitemid 28539342)
14. Schonknecht P, Pantel J, Kruse A, Schroder J (2005) Prevalence and natural course of aging-associated cognitive decline in a population-based sample of young-old subjects. Am J Psychiatry 162(11):2071-2077 (Pubitemid 41598260)
15. Martin P, Martin M (2000) Design und Methodik der Interdisziplinären Längsschnittstudie des Erwachsenenalters. In: Martin P (ed) Aspekte der Entwicklung im mittleren und höheren Erwachsenenalter. Steinkopff, Darmstadt, pp 17-27
16. Wittchen H, Zaudig M, Schramm E, Spengler P, Mombour W, Klug J, Horn R (1991) Strukturiertes klinisches Interview für DSM-III-R. Beltz-Test, Göttingen
17. Levy R (1994) Aging-associated cognitive decline. Working party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 6(1):63-68
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34(7):939-944 (Pubitemid 14076461)
19. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A et al (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN international workshop. Neurology 43(2):250-260 (Pubitemid 23060253)
20. Aslanidis C, Schmitz G (1999) High-speed apolipoprotein E genotyping and apolipoprotein B3500 mutation detection using real-time fluorescence PCR and melting curves. Clin Chem 45(7):1094-1097 (Pubitemid 29340552)
21. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189-198
22. Oswald W, Fleischmann V (1991) Nürnberger Alters-Inventar. Universität Erlangen-Nürnberg, Erlangen
23. Sturm W, Willmes K, Horn W (1993) Leistungsprüfsystem für 50-90jährige. Hogrefe, Göttingen
24. Brickenkamp R (1978) Test d2: Aufmerksamkeits-Belastungstest. Hofgrefe, Göttingen
25. Tewes W (1991) HAWIE-R: Hamburg-Wchsler-Intelligneztest für Erwachsene, revision. Huber, Bern
26. Mielke MM, Zandi PP, Sjogren M, Gustafson D, Ostling S, Steen B, Skoog I (2005) High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 64(10):1689-1695. doi:10.1212/01.WNL.0000161870.78572.A5 (Pubitemid 40695799)
27. Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A (2005) Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 62(10):1556-1560. doi:10.1001/archneur.62.10.1556 (Pubitemid 41434560)
28. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, Tuomilehto J, Nissinen A (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17(1):14-20 (Pubitemid 28153361)
29. Reitz C, Tang MX, Luchsinger J, Mayeux R (2004) Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neurol 61(5):705-714. doi:10.1001/archneur.61.5.70561/5/705 (Pubitemid 38637688)
30. Coffey CE, Saxton JA, Ratcliff G, Bryan RN, Lucke JF (1999) Relation of education to brain size in normal aging: implications for the reserve hypothesis. Neurology 53(1):189-196 (Pubitemid 29329670)
31. Richter V, Rassoul F, Hentschel B, Kothe K, Krobara M, Unger R, Purschwitz K, Rotzsch W, Thiery J, Muradian K (2004) Age-dependence of lipid parameters in the general population and vegetarians. Z Gerontol Geriatr 37(3):207-213. doi:10.1007/s00391-004-0232-3 (Pubitemid 38954455)
32. Mielke M, Zandi P, Shao H, Waern M, Östling S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson D (2010) The 32 year relationship between cholesterol and dementia from midto late-life. Neurology 75(21):1888-1895
33. Gustafson DR, Melchior L, Eriksson E, Sundh V, Blennow K, Skoog I (2010) The ACE insertion deletion polymorphism relates to dementia by metabolic phenotype, APOEepsilon4, and age of dementia onset. Neurobiol Aging 31(6):910-916. doi:10.1016/j.neurobiolaging.2008.07.015
34. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D (1994) Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 6(1):29-32. doi:10.1038/ng0194-29 (Pubitemid 24191909)
35. Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R, Andrews H, Feng L, Tycko B, Mayeux R (1998) The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279(10):751-755 (Pubitemid 28114999)
36. Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, Gureje O, Dickens J, Evans R, Smith-Gamble V, Unverzagt FW, Shen J, Hendrie H (2006) Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology 66(2):223-227. doi:10.1212/01.wnl.0000194507.39504.17 (Pubitemid 43970158)
37. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537. doi:10.1146/annurev. genom.1.1.507
38. Sing CF, Davignon J (1985) Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 37(2):268-285 (Pubitemid 15053161)
39. Wehr H, Parnowski T, Puzynski S, Bednarska-Makaruk M, Bisko M, Kotapka-Minc S, Rodo M, Wolkowska M (2000) Apolipoprotein E genotype and lipid and lipoprotein levels in dementia. Dement Geriatr Cogn Disord 11(2):70-73 (Pubitemid 30114087)
40. Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD (2008) Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 71(5):344-350. doi:10.1212/01.wnl.0000319647.15752.7b
41. Rockwood K (2006) Epidemiological and clinical trials evidence about a preventive role for statins in Alzheimer's disease. Acta Neurol Scand 185:71-77. doi:10.1111/j.1600-0404.2006.00688.x
42. Beydoun MA, Beason-Held LL, Kitner-Triolo MH, Beydoun HA, Ferrucci L, Resnick SM, Zonderman AB (2011) Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment. J Epidemiol Community Health 65(11):949-957. doi:10.1136/jech.2009.100826